Understand the challenges and impacts of the 3Rs on animal welfare in research with Dr. Liz Nunamaker's expert interview.

Learn about the innovative method to create aptamers that could revolutionise treatments for infectious diseases.

Explore the potential of protein design with the new deep learning approach from Chongqing University to enhance binding ...

Learn how antibody to payload design is crucial for advancing ADC technology in oncology and beyond with expert insights.

Learn how radiopharmaceuticals are transforming nuclear medicine and cancer therapy through targeted diagnostics and ...

Explore the collaboration between lab and data scientists to overcome communication challenges in life sciences.

Cytokine release syndrome (CRS) is a major barrier in cancer immunotherapy – but what if we could prevent it before it begins? Dr Liam Tremble, Principal Scientist at Poolbeg Pharma, discusses how ...

Scientists have developed a new drug, SHP1705, that targets hijacked circadian clock proteins used by glioblastoma stem cells to grow and resist treatment. Glioblastoma, the most aggressive form of ...

Explore how multimodal AI is transforming drug development by integrating diverse data sources to accelerate discovery.

Cell and gene therapy is rapidly transforming the treatment of complex diseases, yet scaling production efficiently remains a challenge. Dr Tia Harmon from PHC Corporation of North America explores ...

A new study reveals how tumours hijack fat metabolism to suppress immune responses – and how a novel antibody, PLT012, may reverse this effect, offering new hope for treating immunotherapy-resistant ...

Huntington’s disease remains a major challenge, but allele-selective gene editing offers new hope. By targeting only the mutant gene, this approach could provide a one-time, durable treatment. Life ...